Schonfeld Strategic Advisors’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Schonfeld Strategic Advisors’s Portfolio GRCL Stock Details GRCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell
2023 Q3	$2.19M	Buy
2023 Q2	$2.07M	Sell
2023 Q1	$1.14M	Buy
2022 Q4	$862K	Buy
2022 Q3	$870K	Buy
2022 Q2	$1.42M	Buy
2021 Q3	–	Sell
2021 Q2	$486K	Sell
2021 Q1	$822K	Buy